By Colin Kellaher
Galapagos's number-two executive, Thad Huston, is leaving the biotechnology company after just over two years on the job.
Galapagos on Tuesday said Huston, who joined the Belgium-based company in July 2023 as chief operating and financial officer from Gilead's Kite Pharma unit, plans to depart effective Aug. 1 to return to the U.S. for personal and professional reasons.
The company said it expects to announce Huston's successor in the coming months.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
April 15, 2025 06:06 ET (10:06 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.